Stoke Therapeutics, Inc. ( STOK) - Stock Earnings
STOK Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 3, 2026, midnight | — / — | — | — / — | — |
STOK Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -57.9 million USD | 1.4 million USD |
| 2026Q1 | -50.0 million USD | 6.2 million USD |
| 2026Q2 | -61.6 million USD | 9.3 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
STOK Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -104.7 million USD | 8.8 million USD |
| 2024 | -89.0 million USD | 36.6 million USD |
| 2025 | -6.9 million USD | 184.4 million USD |
| 2026 Est. | — | — |
STOK
Price: $24.18
52 week price:
Earnings Per Share: -3.39 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 66686
Market Capitalization: 1.7 billion